In consideration of the well known presence of VEGF in melanoma microenvironment35 it seems possible that this signaling pathway is active also in vivo, hence to hypothesise that it has contributed to the overall inhibitory effect of Ned-19 treatment in our in vivo model. Here, VEGFA is linked to melanoma.